🔎 Trials Near Me

Akèy › Melanom Uveal › Tennessee › Nashville

Etid klinik pou Melanom Uveal nan Nashville, TN

6 etid pou Melanom Uveal ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

Ap rekriteFaz 3
  • Sarah Cannon Research Institute (SCRI), Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07804186

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

Ap rekriteFaz 1/2
  • Sarah Cannon Research Institute, Nashville
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT06940739

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Ap rekriteFaz 1/2
  • The Sarah Cannon Research Institute/Tennessee Oncology, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT03947385

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Ap rekriteFaz 3
  • SCRI Oncology Partners, Nashville
  • Vanderbilt Eye Institute, Nashville
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Ap rekriteFaz 2/3
  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic), Nashville
Tout laj · Tout sèks · Mizajou Apr 2, 2026 · NCT06581406

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

Ap rekriteFaz 1/2
  • SCRI Oncology Partners, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Nov 28, 2025 · NCT07136181

Etid Melanom Uveal nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.